Oesophageal squamous cell carcinomas and oesophageal adenocarcinomas show distinct patterns of ErbB expression and dimers. The functional effects of specific ErbB homodimers or heterodimers on oesophageal (cancer) cell behaviour, particularly invasion during early carcinogenesis, remain unknown. Here, a new cellular model system for controlled activation of epidermal growth factor receptor (EGFR) or human epidermal growth factor receptor 2 (HER2) and EGFR-HER2 or HER2-human epidermal growth factor receptor 3 (HER3) homodimers and heterodimers was studied in non-neoplastic squamous oesophageal epithelial Het-1A cells. EGFR, HER2 and HER3 intracellular domains (ICDs) were fused to dimerization domains (DmrA/DmrA and DmrC), and transduced into Het-1A cells lacking ErbB expression. Dimerization of EGFR, HER2 or EGFR-HER2 and HER2-HER3 ICDs was induced by synthetic ligands (A/A or A/C dimerizers). This was accompanied by phosphorylation of the respective EGFR, HER2 and HER3 ICDs and activation of distinct downstream signalling pathways, such as phospholipase C1, Akt, STAT and Src family kinases. Phenotypically, ErbB dimers caused cell rounding and non-apoptotic blebbing, specifically in EGFR-HER2 and HER2-HER3 heterodimer cells. In a Transwell assay, cell migration velocity was elevated in HER2 dimer cells as compared with empty vector cells. In addition, HER2 dimer cells showed in increased cell invasion, reaching significance for induced HER2-HER3 heterodimers (P = 0.015). Importantly, in three-dimensional organotypic cultures, empty vector cells grew as a superficial cell layer, resembling oesophageal squamous epithelium. In contrast, induced HER2 homodimer cells were highly invasive into the matrix and formed cell clusters. This was associated with partial loss of cytokeratin 7 (when HER2 homodimers were modelled) and p63 (when EGFR-HER2 heterodimers were modelled), which suggests a change or loss of squamous cell differentiation. Controlled activation of specific EGFR, HER2 and HER3 homodimers and heterodimers caused oesophageal squamous epithelial cell migration and/or invasion, especially in a three-dimensional microenvironment, thereby functionally identifying ErbB homodimers and heterodimers as important drivers of oesophageal carcinogenesis.
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heterodimerize, activate multiple signalling pathways, and guide subsequent cell behaviour [1] [2] [3] [4] . As somatic or cancer cells can express more than one ErbB receptor or ligand, receptor activation results in a complex signalling network [1] [2] [3] [4] . This complicates the understanding of how one specific homodimer or heterodimer contributes to cell signalling, cell behaviour, or potential malignant transformation.
In both histotypes of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC) and oesophageal adenocarcinoma (EAC) [5] , ErbB amplification or overexpression is seen [5] [6] [7] [8] [9] [10] [11] . EGFR overexpression is often found in ESCCs, whereas HER2 and/or HER3 are overexpressed in EACs [5] [6] [7] [8] [9] [10] [11] . Accordingly, EGFR homodimers are present in ESCCs, and HER2 homodimers and HER2-HER3 heterodimers are present in EACs [8] . However, the precise contribution of specific ErbB dimers to oesophageal cancer cell behaviour, carcinogenesis or cancer progression is not understood.
In general, ErbB homodimers are less mitogenic and transforming than the corresponding heterodimers [2] . HER2-containing heterodimers are considered to be the most potent, especially HER2-HER3 heterodimers [2] . This was shown in a model of growth-arrested mammary acini, which rely on ductal/glandular epithelial cells: HER2 homodimers reinitiated cell proliferation and disrupted cell polarity [12] , but EGFR-HER2 heterodimers even induced invasion [13] . These models therefore contribute to our understanding of adenocarcinomas arising from their precursor ductal epithelial cells. As the output of the ErbB signalling network depends on the cellular origin [1] [2] [3] [4] , the functional effects of specific ErbB homodimers or heterodimers on oesophageal squamous epithelial cells in terms of signalling and cell behaviour, especially cell morphology (squamous or glandular/intestinal) and cell migration and invasion as early steps of carcinogenesis of either ESCC or EAC, is so far unknown.
In previous studies, forced EGFR overexpression in oesophageal epithelial cells indicated that EGFR is important for cell proliferation, migration, or epithelial-mesenchymal transition [14] [15] [16] . In contrast, we and others reported that inhibition of EGFR and/or HER2 in ESCC or EAC cells by tyrosine kinase inhibitors (TKIs) reduced cell proliferation and induced apoptosis [8, [17] [18] [19] . Moreover, we showed that TKIs also inhibited oesophageal cancer cell migration [20] .
However, studies investigating the effects of specific EGFR, HER2 or HER3 dimers on oesophageal squamous epithelial cells are lacking. Hence, the precise role of ErbB homodimers or heterodimers in oesophageal (cancer) squamous cell behaviour, including cell proliferation, migration, or invasion, and thereby in oesophageal carcinogenesis or progression, is poorly understood. Furthermore, it is unclear whether distinct ErbB expression or dimerization patterns observed in ESCC and EAC are involved in early steps of carcinogenesis or metastasis.
Here, we addressed this question for the first time by using non-neoplastic squamous oesophageal epithelial Het-1A cells [8] , which lack endogenous ErbB (over)expression and dimers, for transduction with constructs containing EGFR, HER2 or HER3 intracellular domains (ICDs) connected to dimerization domains DmrA or DmrC. DmrA is based on the human protein FKBP12, a target for FK506 and rapamycin. DmrC is a mutated 93 amino acid portion of the phosphoinositide 3-kinase (PI3K) homologue FRAP. Rapamycin functions by binding to FKBP and to FRAP, thereby joining the two proteins as a heterodimerizer [13] . These Dmr domains can hence be utilized to induce dimerization of the ErbB-Dmr-containing chimaeric proteins by synthetic ligands, which can be constructed as analogues of rapamycin. Therefore, the commercial synthetic ligands known as A/A Homodimerizer and A/C Heterodimerizer dimerize DmrA and DmrC, while not being able to bind to wild-type endogenous FRAP [21, 22] . This allows controlled homodimerization of EGFR or HER2 and heterodimerization of EGFR-HER2 or HER2-HER3 by A/A Homodimerizer and A/C Heterodimerizer treatments.
Hence, this cellular model system enabled us to precisely study the effects of specific ErbB dimers on signalling pathways and oesophageal cell behaviour, such as cell morphology, migration, and invasion. Moreover, by the use of three-dimensional organotypic cultures (OTCs) of the transduced oesophageal squamous epithelial cells, the potential of malignant transformation was studied in terms of histopathological assessment of cell morphology, differentiation, and cell invasion into a deeper OTC matrix. In an exploratory approach, OTCs showing the most significant phenotype differences were further examined by the use of matrix-assisted laser desorption/ionization Fourier-transform ion cyclotron resonance mass spectrometry imaging (MALDI-FT-ICR MSI) for metabolomic profiling [23, 24] .
Materials and methods

DNA constructs
Details of DNA construct preparation are provided in supplementary materials, Supplementary materials and methods. After each cloning step, vectors were subjected to sequencing to verify the nucleotide sequences.
An ErbB dimer model of oesophageal (cancer) cell migration/invasion 483
Cell culture and stable cell lines Het-1A cells (ATCC, LGC Standards, Wesel, Germany; non-neoplastic oesophageal squamous epithelial cells, lacking ErbB (over-)expression or dimers) [8] were cultured as described previously [8] . Authentication was performed by short tandem repeat DNA typing [25] (Leibniz Institute DSMZ, Braunschweig, Germany). Cells were negative for mitochondrial DNA sequences from rodent cells (mouse, rat, and Chinese and Syrian hamster species). Stable Het-1A cells expressing ErbB ICD fusion proteins were generated and controlled for the absence of Mycoplasma contamination as described in detail in supplementary material, Supplementary materials and methods.
To activate ErbB dimerization, 300 nM A/A Homodimerizer (Clontech) in ethanol or ethanol as control (final concentration of ethanol 0.06%) was used for H-e.v.-A/A, H-H1/1 and H-H2/2 cells, whereas 300 nM A/C Heterodimerizer (Clontech) in ethanol or ethanol as control (final concentration of ethanol 0.06%) was used for H-e.v.-A/C, H-H1/2 and H-H2/3 cells.
Indirect immunofluorescence
Indirect immunofluorescence experiments were performed as described previously [8, 20, 26] , with anti-HA-Tag and anti-Flag-Tag antibodies (supplementary material, Table S1 ).
Western blotting
Protein lysates and western blots were prepared as described previously [8] , and details of all antibodies used are provided in supplementary material, Table S1 . Entire western blots (up to 250 kDa) for determination of the phosphorylation status of transduced ErbB ICD fusion proteins and endogenous ErbB proteins are provided in supplementary material, Figures S3 and S4.
Antibody array
Cells were serum-starved [medium +0.5% fetal bovine serum (FBS)] for 24 h. Medium was replaced by starvation medium containing ethanol as a control, 300 nM A/A Homodimerizer in ethanol or 300 nM A/C Heterodimerizer in ethanol for 24 h, then a Proteom Profiler Human Phospho-Kinase Array (R&D Systems, Abingdon, UK) was used according to the manufacturer's instruction. Quantification of the pixel density of duplicate spots was performed with ImageJ 1.47v software in two independent experiments. See also supplementary material, Table S2 .
Phalloidin staining and evaluation of blebbing cells
Phalloidin staining was performed as described previously [20] . Cells were serum-starved (medium +0.5% FBS) for 24 h, and medium was replaced by starvation medium containing ethanol as a control, 300 nM A/A Homodimerizer in ethanol or 300 nM A/C Heterodimerizer in ethanol for 24 h. In three independent experiments, ≥100 cells were randomly captured and evaluated for the occurrence of blebbing cells (blebbing cells/total cells as percentage).
Organotypic culture
OTC was performed by use of a published protocol [27] , with modifications. First, a matrix mainly consisting of Matrigel, collagen and fibroblasts [here, fetal oesophageal fibroblasts 3 (FEF3)] were cultured in Transwell chambers. Upon dislodgement of matrices from the insert wall on day 2, the fibroblasts organized and were left to contact the Matrigel-collagen matrix for 5 days, which then resembled connective tissue. Thereafter, transduced cells, previously stimulated with medium containing ethanol as a control, 300 nM A/A Homodimerizer in ethanol or 300 nM A/C Heterodimerizer in ethanol from days 2 to 5, were plated on top of this matrix. From then on, cells were fed with Epidermalization medium I [27] containing ethanol as a control, 300 nM A/A Homodimerizer in ethanol or 300 nM A/C Heterodimerizer in ethanol until day 17 (i.e. for 2 weeks). Thereafter, cells were exposed to an air-liquid interface to trigger epithelial differentiation, and fed with Epidermalization medium II [27] , containing ethanol as a control, 300 nM A/A Homodimerizer in ethanol or 300 nM A/C Heterodimerizer in ethanol for 5 days. Harvested OTCs were fixed in 10.0% formaldehyde and embedded in paraffin, by the use of routine diagnostic automated tissue processing. Haematoxylin and eosin (H&E) staining of OTC sections was performed from each of four grossing levels per harvested OTC with automated systems and reagents (Dako CoverStainer; Agilent, Hamburg, Germany). Three independent experiments for each 3-week round of OTCs were performed.
Immunohistochemistry of OTCs
For immunohistochemistry, 2-μm-thick serial sections of one grossing level selected from the initial H&E-stained OTCs were deparaffinized, subjected to antigen retrieval, and incubated with primary antibodies as described in supplementary material, Table S1 . After washing, all reactions were continued with the Dako EnVision FLEX+ Visualization System on the Autostainer System (all DakoCytomation, Agilent, Hamburg, Germany). Analysis was according to positivity of cells, not staining intensity.
Statistical analyses
To compare untreated and A/A Homodimerizer-treated or A/C Heterodimerizer-treated cells, two-tailed, paired Student's t-tests were performed. A P value of <0.05 was considered to be statistically significant.
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Results
Cellular model system for controlled activation of ErbB homodimers and heterodimers
The cellular model system ( Figure 1A-F) was based on Het-1A non-neoplastic squamous oesophageal epithelial cells, which express the ErbB receptors and form dimers at negligible levels, especially as compared with ESCC or EAC cells overexpressing EGFR or HER2 [8] . These cells were transduced with empty vector controls ( Figure 1A, D 
Activated ErbB dimers induce distinct downstream signalling pathways, but do not increase cell proliferation
To examine signalling pathways associated with ErbB-dimer activation, Human Phospho-Kinase Arrays reflecting site-specific phosphorylation of 38 kinases and two related total proteins (β-catenin and heat shock protein 60) at 24 h after dimerizer treatment, as well as additional western blots for two phosphorylation sites of the EGFR-HER2-phospholipase Cγ1 (PLCγ1) axis [28, 29] , were performed.
ErbB dimer cells showed general alterations in PI3K-AKT, TOR, PLCγ1, STAT and Src-family kinases of >1.5-fold as compared with their paired non-induced cells (supplementary material, Table S2 ); however, this was variable, and in part also observed in empty vector control cells. Following normalization to corresponding non-induced empty vector control cell data, activated EGFR homodimers were seen to have caused STAT6, Src family kinase (Yes and Hck), c-Jun and PLCγ1 Tyr783 phosphorylation, whereas activated HER2 homodimers caused Akt, variable STAT5 and STAT6 as well as Src family kinase (Yes, Hck, and Lyn) phosphorylation (Figure 2A ). Activated EGFR-HER2 heterodimers caused STAT5b, STAT6, Src family kinase (Yes and Hck) and JNK phosphorylation, whereas, in HER2-HER3 cells, controlled activation led to JNK phosphorylation, with other proteins being variably phosphorylated ( Figure 2B ). Except for EGFR-EGFR cells, no marked phosphorylation of PLCγ1 at Tyr783 was seen in induced ErbB dimer cells as compared with empty vector control cells in this analysis (Figure 2A, B) . Western blot analyses of PLCγ1 Tyr783 and PLCγ1
Ser1248 at 8 and 24 h after dimerization ( Figure 2C ) showed some background activation, i.e. the presence of both PLCγ1
Tyr783 and PLCγ1
Ser1248 already at 0 h in non-induced empty vector control (H-e. Tyr783 was not detected and was stable (i.e. with background activation at 0 h) in ErbB heterodimer (H-H1/2 and H-H2/3) cells. Phosphorylation of PLCγ1
Ser1248 was similarly stable, without significant changes upon induction of dimerization in all cells.
Although several of the altered signal proteins are involved in cell proliferation [30] [31] [32] [33] [34] , no marked effect was seen on cell proliferation, except for upregulation of cyclin D1 (CCND1) mRNA levels in HER2-HER2 (H-H2/2) cells (supplementary material, Figure S5A , B) and slightly elevated cell proliferation in H-e.v.-A/A and HER2-HER2 (H-H2/2) cells (supplementary material, Figure S5C -H).
As analysed by F-actin staining, empty vector control H-e.v.-A/A and H-e.v.-A/C cells had widespread cytoplasm with several stress fibres, and there were no obvious morphological changes after A/A Homodimerizer or A/C Heterodimerizer treatment ( Figure 3A,  D) . Similar morphologies were seen in non-activated EGFR (H-H1/1) and HER2 (H-H2/2) homodimer or EGFR-HER2 (H-H1/2) and HER2-HER3 (H-H2/3) cells, except for H-H1/2 and H-H2/3 cells showing round morphology ( Figure 3B , C, E, F; arrows). However, upon homodimer or heterodimer activation, more ErbB cells became round ( Figure 3B , C, E, F; arrows), and membrane blebbing occurred as a trend in H-H1/2 cells and significantly in H-H2/3 cells (P = 0.041) (Figure 3E-H; arrowheads) .
Membrane blebbing may occur during apoptosis, cytokinesis, or cell migration [35, 36] . Assessment of apoptosis via nuclear condensation or fragmentation or expression of the caspase-cleaved cytokeratin (CK) 18 neo-epitope M30 did not yield signs of apoptosis in blebbing and hence pointed to migrating H-H1/2 and H-H2/3 cells (supplementary material, Figure S6B 
ErbB homodimers and heterodimers induce cell invasion in organotypic cultures
To more closely mimic the in situ situation, the influence of ErbB dimers was further studied in three-dimensional OTCs [27] .
H-e.v.-A/A cells formed non-invasive squamous epithelial layers and A/A Homodimerizer treatment failed to induce EGFR or HER2 phosphorylation or morphological changes ( Figure 4A ). H-H1/1 cells were also non-invasive, but non-induced and induced H-H1/1 cells showed slightly increased epithelial thickness. Here, EGFR homodimer activation slightly induced EGFR phosphorylation and invasion of selected cells ( Figure 4B Figure 5B ). However, EGFR-HER2 activation in H-H1/2 cells strongly increased EGFR and HER2 phosphorylation, resulting in a very thick and pleomorphic epithelial layer with highly invasive cells ( Figure 5B) . Similarly, non-activated H-H2/3 cells showed some thickening and borderline invasion of the epithelial layer, but this was markedly reinforced by HER2-HER3 activation ( Figure 5C ). Thereby, activation resulted in more phospho-HER2-positive and phospho-HER3-positive cells ( Figure 5C ).
ErbB dimers alter cell differentiation and metabolomic states in OTCs
Cell proliferation was similarly high in all of the ErbB dimer and empty vector control cells in OTCs (supplementary material, Figure S8A-F) , hence excluding dimerization-dependent cell proliferation as the basis for the increased epithelial layer thickness in OTCs.
Cell invasion is associated with reduced formation of focal contacts [37, 38] , but focal adhesion kinase (FAK) expression was prominent in OTCs (supplementary material, Figure S8G -L), except in activated EGFR-HER2 (H-H1/2) OTCs, which showed fewer FAK-positive cells (supplementary material, Figure S8K ).
Therefore, cell differentiation in OTCs was assessed by use of the routine diagnostic markers p63 and CK7, which are more frequently, but not exclusively, expressed in ESCC and EAC, respectively [39] [40] [41] . CDX2, which marks glandular/intestinal differentiation in EACs, was confirmed to be absent by routine diagnostic immunohistochemistry, which was expected in view of the lack of glands in H&E-stained OTCs.
In OTCs of all transduced, non-induced cells, both p63-positive and CK7-positive cells were present. No marked changes in p63 or CK7 were detected in induced H-e.v.-A/A, H-H1/1 or H-H2/2 cells (Figure 6A-C) . However, CK7-positive cells were more frequent and stable in non-activated and activated H-H1/2 and H-H2/3 cells than in H-e.v.-A/C cells ( Figure 6D-F) . In contrast, there were fewer p63-positive cells in activated than in non-activated H-H1/2 cells (supplementary material, Figure S6E ), suggesting loss of original epithelial differentiation.
Finally, exploratory MALDI-FT-ICR MSI experiments [23, 24] were performed with OTCs from non-induced and induced empty vector control Representative images of H&E-stained OTCs are shown. Phosphorylation of EGFR and HER2 was detected by immunohistochemistry (brown staining). All upper panels are at the same magnification. Scale bar: 100 μm. The lower panels with black frames show a magnified view (×5). H&E and immunohistochemistry stains are representative of three independent biological experiments. P-EGFR, phosphorylated EGFR; P-HER2, phosphorylated HER2.
(H-e.v.-A/C) and HER2-HER3 (H-H2/3) cells, which showed the most altered phenotype. Indeed, the metabolomic profiles were also specifically changed upon induction of HER2-HER3 (supplementary material, Figure S9) . Thereby, the levels of a majority of metabolites were similarly altered (increase or decrease) in induced versus non-induced cells (H-e.v.-A/C and H-H2/3 cells), most likely reflecting traces of A/C Heterodimerizer action and associated metabolites. However, several metabolites were also exclusively detected at high levels in induced HER2-HER3 (H-H2/3) cells.
Discussion
ErbB overexpression or gene amplification occurs in both histotypes of oesophageal cancer [5] [6] [7] [8] [9] [10] [11] , with preferential EGFR overexpression and homodimers in ESCCs, and HER2 overexpression and HER2 homodimers or HER2-HER3 heterodimers in EACs [8] . However, the functional effects of specific ErbB dimers on oesophageal squamous epithelial cell behaviour with respect to early steps of carcinogenesis are still unknown. We here present a new cellular model system for controlled activation of ErbB homodimers or 492 CD Fichter et al heterodimers in non-neoplastic oesophageal squamous epithelial Het-1A cells, which intrinsically lack marked (over)expression of endogenous ErbB receptors or ErbB dimers [8] , and report that specific ErbB dimers cause an invasive phenotype in OTCs, mimicking early steps of oesophageal carcinogenesis.
Our model system is based on ICDs of selected ErbB family receptors in order to allow controlled, ligand-independent -activation. Hence, this may not fully recapitulate the 'real-world' situation of ErbB family receptors in oesophageal carcinomas. However, a predominance or even exclusivity of expression, dimerization and function of EGFR, HER2 or HER3 was reported in several oesophageal cancer cell lines and oesophageal carcinomas in situ [8, 20] . Moreover, in the present study, mere activation of ErbB dimers via ICDs was sufficient for an invasive, malignant phenotype in three-dimensional OTCs. As shown by MALDI-FT-ICR MSI [23, 24] , not only signalling pathways, but also metabolomic profiles, were altered upon HER2-HER3 dimerization of H-H2/3 cells in OTCs, accompanying their invasive phenotype. At the routine histological level, OTCs of EGFR-HER2 and HER2-HER3 cells showed a stable high frequency of CK7-positive cells, but a lower frequency of p63-positive cells upon induction of EGFR-HER2 cells. Intestinal/glandular precursor lesions and EACs are mainly CK7-positive [39] . p63 staining is positive in stratified epithelia [40, 41] , and is lost upon cell migration, invasion and metastasis [40, 42, 43] , as well as upon squamous cells transdifferentiating into intestinal/glandular precursor lesions of EAC [44] . The transcription factor CDX2, which is associated with intestinal/glandular epithelial precursor lesions and EAC [39, 44, 45] , was absent in our OTCs, which, at 3 weeks of culture, did not (yet) show overt glands. Hence, the pattern of CK7 and p63 observed in the ErbB dimer OTCs at 3 weeks of growth -at least partially -appears to reflect early steps of carcinogenesis, at which time oesophageal squamous epithelial cells become invasive and start to dedifferentiate. Thus, mere induction of ErbB dimer ICDs causes overt phenotypic changes and thereby also underlines other reports in which ErbB receptors act independently of ligands and/or may even present as extracellular truncated EGFR (or EGFRvIII) or cleaved HER2 (p. 95) proteins [46, 47] .
Our findings obtained with this oesophageal cell model may be compared with studies on growth-arrested mammary acini [12, 13] . In the latter, which is a mammary (ductal/glandular) cell model, EGFR homodimers did not alter acinar structures [12] , whereas HER2 homodimers and especially EGFR-HER2 heterodimers disrupted polarized acinar organization [12, 13] and induced matrix composition-dependent invasive protrusions [13] . Hence, our data underline a general function of ErbB homodimers and heterodimers in epithelial cell migration and invasion, and underscore their functional impact also on oesophageal cell behaviour.
Interestingly, some studies of HER2 structure proposed that it cannot form homodimers [48] , which appears to somewhat contradict the above findings in oesophageal and mammary epithelial cell models and carcinomas. However, several studies have demonstrated the presence of HER2 homodimers in cancer cell lines and/or human cancer tissue specimens [49] [50] [51] [52] . In addition, the extracellular domain of HER2 is reminiscent of the ligand-bound forms of other ErbB receptors, and HER2 is constitutively extended, exposing its dimerization arm, so that it is constantly primed for interaction [4] . Moreover, other basic research studies have reported the molecular and structural architecture of an ErbB2 homodimer [53] . Therefore, the presence of high membranous levels of HER2, occurring in EACs because of gene amplification [11] , may result in HER2 homodimer formation, which was also shown in our previous study on oesophageal cancer cell lines and oesophageal carcinomas [8] .
In our model system, activation of EGFR, HER2 and HER3 homodimers or heterodimers induced distinct patterns of ErbB (ICD) phosphorylation and associated downstream signalling pathway activation. Thereby, monolayer cultures harvested at early time points (0-72 h after dimerization) showed different levels of HER2 and HER3 phosphorylation from those same cells cultured in 3D OTCs, which needed 3 weeks for 'building'. This may actually indicate that, also in human carcinomas in situ, the phosphorylation dynamics of ErbB receptors differ from those studied in short-duration monolayer experimental cell line culture settings.
As the original Het-1A cells are also intrinsically highly proliferative, ErbB dimer induction and phosphorylation had no marked effect on cell proliferation. Only a slight increase in the level of Akt phosphorylation with parallel upregulation of CCND1 mRNA expression was seen in HER2 homodimer cells. Instead, controlled activation of ErbB homodimers and heterodimers resulted in activation of distinct STAT transcription factors, Src family kinases, and PLCγ1, all of which are associated with round cell morphology, non-apoptotic blebbing, and (amoeboid) cell migration and invasion [30] [31] [32] [33] [34] [35] [36] [37] [38] . Accordingly, cell rounding occurred in almost all induced ErbB dimer cells, being more evident upon heterodimer activation. Furthermore, EGFR-HER2 and HER2-HER3 activation caused non-apoptotic blebbing, cell migration, and invasion. In fact, EGF induced ErbB dimer-associated, non-apoptotic blebbing and migration of prostate cancer cells [54] . Cells moving in such an amoeboid manner may be influenced by the composition and compactness of the extracellular matrix [35] [36] [37] [38] . Although this aspect was not further studied functionally in vitro or in the OTCs, the phenotype of the invasive ErbB dimer cells in OTCs underlines these cell movements.
In summary, controlled activation of specific EGFR, HER2 and HER3 homodimers and heterodimers caused oesophageal squamous epithelial cell migration and invasion, especially in a three-dimensional microenvironment, thereby functionally identifying ErbB homodimers and heterodimers as important drivers of oesophageal carcinogenesis. Table S1 . Primary antibodies used in this study 
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